Velcade bortezomib: Updated Phase II data

Updated data from an open-label Phase II trial in 48 evaluable patients with

Read the full 130 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE